Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

Journal of Neuroscience

Volumn 18, Issue 6, 1998, Pages 1979-1986

  Jones, Sara R ^a   Gainetdinov, Raul R ^a   Mark Wightman, R ^b   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Amphetamine; Dopamine; Dopamine transporter; Knockout; Mice; Microdialysis; Ro4 1284; Synaptic vesicles; Tetrabenazine; Voltammetry

Indexed keywords

2 ETHYL 1,2,3,4,6,7 HEXAHYDRO 2 HYDROXY 3 ISOBUTYL 9,10 DIMETHOXY 11BH BENZO[A]QUINOLIZINE; AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; NIALAMIDE; PARGYLINE; PSYCHOSTIMULANT AGENT; RESERPINE; SULPIRIDE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG MECHANISM; ELECTROSTIMULATION; MALE; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; TRANSPORT KINETICS;

EID: 0032521354     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-06-01979.1998     Document Type: Article

References (56)

1. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93.
2. Bosse R, Fumagalli H, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG (1997) Anterior pituitary hypoplasia and dwarfisn in mice lacking the dopamine transporter. Neuron 19:127-138.
3. Burnette WB, Bailey MD, Kukoyi S, Blakely RD, Trowbridge CG, Justice JB Jr (1996) Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68:2932-2938.
4. Butcher SP, Fairhrother IS, Kelly JS, Arbuthnott GW (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J Neurochem 50:346-355.
5. Cadoni C, Pinna A, Russi G, Consolo S, Di Chiara G (1995) Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience 65:1027-1039.
6. Callaway CW, Kuczenski R, Segal DS (1989) Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine. Brain Res 505:83-90.
7. Chiueh CC, Moore KE (1975) D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. J Pharmacol Exp Ther 192:642-653.
8. Colzi A, D'Agostini R, Cesura AM, Borroni E, Da Prada M (1993) Monoamine oxidase-A inhibitors and dopamine metabolism in rat - caudatus: evidence that an increased cytosolic level of dopamine dis- places reversible monoamine oxidase-A inhibitors in vivo. J Pharmacol Exp Ther 265:103-111.
9. Creese I, Iverson SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419-436.
10. Erickson JD, Schafer MK-H, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166-5171.
11. Eshleman AJ, Henningsen RA, Neve KA, Janowsky A (1993) Release of dopaminc via the human transporter. Mol Pharmacol 45:312-316.
12. 3H]NA in cell bodies and terminals. Gen Pharmacol 25:1039-1043.
13. Fischer JF, Oho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
14. Floor E, Meng L (1996) A mphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett 215:53-56.
15. Floor E, Leventhal PS, Wang Y, Meng L, Chen W (1995) Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J Neurochem 64:689-699.
16. Franklin KBJ, Paxinos G (1996) The mouse brain in stereotaxic coordinates. San Diego: Academic.
17. Gainetdinov RR, Fumagalli F, Jones SR, Caron MG (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem 69:1322-1325.
18. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
19. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
20. Green AL, EI Haut MJ (1978) Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo. J Pharm Pharmacol 30:262-263.
21. 3H-dopamine in rat brain tissue slices. Biochem Pharmacol 24:847-852.
22. Horn AS (1990) Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 34:387-400.
23. Hurd YL, Ungerstedt U (1989) Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 166:261-269.
24. Iravani M, Kruk ZL (1995) Effects of AMPH on carrier-mediated and electrically stimulated DA release in slices of rat caudate putamen and nucleus accumbens. J Neurochem 64:1161-1168.
25. Jones SR, Garris PA, Kilts CD, Wightman RM (1995a) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudateputamen and nucleus accumbens of the rat. J Neurochem 64:2581-2589.
26. Jones SR, Garris PA, Wightman RM (1995b) Different effects of cocaine and nomifensine on DA uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp Ther 274:396-403.
27. Kawagoe KT, Zimmerman JB, Wightman RM (1993) Principles of voltammetry and microelectrode surface states. J Neurosci Methods 48:225-240.
28. Knepper SM,. Grunewald GL, Rutledge CO (1988) Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. J Pharmacol Exp Ther 247:487-494.
29. Koob GR, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
30. Kuczenski R, Segal DS, Manley LD (1990) Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates. J Neurochem 54:1492-1499.
31. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem Pharmacol 31:983-992.
32. Liang NY, Rutledge CO (1982b) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31:2479-2484.
33. Mack F, Bonisch H (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch Pharmacol 310:1-9.
34. Miller HH, Shore PA, Clarke DE (1980) In vivo monoamine oxidase inhibition by D-amphetamine. Biochem Pharmacol 29:1347-1354.
35. Parker EM, Cubeddu LX (1986a) Effects of D-amphetamine and dopamine synthesis inhibitors on dopaminc and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J Pharmacol Exp Ther 237:179-192.
36. Parker EM, Cubeddu LX (1986b) Effects of D-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J Pharmacol Exp Ther 237:193-203.
37. Peter D, Jimenez J, Liu Y, Kim J, Edwards RH (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem 269:7231-7237.
38. Pierce RC, Kalivas PW (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254-3262.
39. Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47:368-373.
40. Raiteri M, Cerrito F, Cervoni AM, Levi G (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195-202.
41. Scheel-Kruger J (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the rat brain. Eur J Pharmacol 14:47-59.
42. Schuldiner S, Steiner-Mordoch S, Rodrigo Y, Wall SC, Rudnick G (1993) Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol Pharmacol 44:1227-1231.
43. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639-677.
44. Self DW, Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495.
45. Sonders MS, Amara SG (1996) Channels in transporters. Curr Opin Neurobiol 6:294-302.
46. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-974.
47. Sulzer D, Rayport S (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chroniaffin granules: a mechanism of action. Neuron 5:797-808.
48. Sulzer D, Pothos E, Sung HM, Maidment NT, Hoebel BG, Rayport S (1992) Weak base model of amphetamine action. Ann NY Acad Sci 654:525-528.
49. Sulzer D, Maidment NT, Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neureochem 60:527-535.
50. Sulzer D, Chen T-K, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
51. Ungerstedt U (1984) Measurement of neurotransmitter release by intracranial dialysis. In: Measurement of neurotransmitter release in vivo (Marsden CA, ed), pp 81-105. Chichester, UK: Wiley.
52. Westerink BHC, Justice Jr JB (1991) Microdialysis compared with other in vivo release models. In: Microdialysis in the neurosciences (Robinson TE, Justice Jr JB, eds), pp 23-43. Amsterdam: Elsevier.
53. Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340.
54. 3H]amphetamine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 257:830-835.
55. 3H[amphetamine with rat brain synaptosomes. I. Saturable sequestration. J Pharmacol Exp Ther 257:820-829.
56. Zetterstrom T, Sharp T, Collin AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur J Pharmacol 148:327-334.